Leukocyte capture and modulation of cell-mediated immunity during human sepsis: An ex vivo study

Critical Care

Volumn 17, Issue 2, 2013, Pages

  Rimmelé, Thomas ^a   Kaynar, Ata M ^a   McLaughlin, Joseph N ^a   Bishop, Jeffery V ^a   Fedorchak, Morgan V ^b   Chuasuwan, Anan ^a   Peng, Zhiyong ^a   Singbartl, Kai ^a   Frederick, Daniel R ^a   Zhu, Lin ^a   Carter, Melinda ^a   Federspiel, William J ^a,b   Zeevi, Adriana ^c   Kellum, John A ^a,b  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF PITTSBURGH   (United States)

^c UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 1BETA; INTERLEUKIN 2; INTERLEUKIN 4; INTERLEUKIN 5; INTERLEUKIN 6; INTERLEUKIN 8; TUMOR NECROSIS FACTOR;

ADULT; ARTICLE; BLOOD FLOW; CELL ADHESION; CELL COUNT; CELL INTERACTION; CIRCULATION; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE RELEASE; EX VIVO STUDY; EXTRACORPOREAL CIRCULATION; FILTER; HEMADSORPTION; HUMAN; IMMUNOMODULATION; INFLAMMATION; INHIBITION KINETICS; LEUKOCYTE; LYMPHOCYTE FUNCTION; MONOCYTE; PRIORITY JOURNAL; PROTEIN EXPRESSION; SCANNING ELECTRON MICROSCOPY; SEPTIC SHOCK; UPREGULATION; ADSORPTION; BLOOD; CELLULAR IMMUNITY; DEVICES; IMMUNOLOGY; PHYSIOLOGY; PROCEDURES; SEPSIS;

ADSORPTION; EXTRACORPOREAL CIRCULATION; HUMANS; IMMUNITY, CELLULAR; LEUKOCYTES; SEPSIS;

EID: 84875358227     PISSN: 13648535     EISSN: 1466609X     Source Type: Journal    
DOI: 10.1186/cc12587     Document Type: Article

References (45)

1. Angus DC, Linde-Zwirble WT, Lidicker J, Clermont G, Carcillo J, Pinsky MR. Epidemiology of severe sepsis in the United States: analysis of incidence, outcome, and associated costs of care. Crit Care Med 2001, 29:1303-1310. 10.1097/00003246-200107000-00002, 11445675.
2. Cruz DN, Antonelli M, Fumagalli R, Foltran F, Brienza N, Donati A, Malcangi V, Petrini F, Volta G, Bobbio Pallavicini FM, Rottoli F, Giunta F, Ronco C. Early use of polymyxin B hemoperfusion in abdominal septic shock: the EUPHAS randomized controlled trial. JAMA 2009, 301:2445-2452. 10.1001/jama.2009.856, 19531784.
3. Kellum JA, Uchino S. International differences in the treatment of sepsis: are they justified?. JAMA 2009, 301:2496-2497. 10.1001/jama.2009.850, 19531792.
4. Lindenauer PK, Rothberg MB, Nathanson BH, Pekow PS, Steingrub JS. Activated protein C and hospital mortality in septic shock: a propensity-matched analysis. Crit Care Med 2010, 38:1101-1107. 10.1097/CCM.0b013e3181d423b7, 20154607.
5. Kalil AC. Does recombinant activated protein C work in patients with severe sepsis?. Crit Care Med 2010, 38:1217-1220. 10.1097/CCM.0b013e3181d53b63, 20335704.
6. Busund R, Koukline V, Utrobin U, Nedashkovsky E. Plasmapheresis in severe sepsis and septic shock: a prospective, randomised, controlled trial. Intensive Care Med 2002, 28:1434-1439. 10.1007/s00134-002-1410-7, 12373468.
7. Honore PM, Jamez J, Wauthier M, Lee PA, Dugernier T, Pirenne B, Hanique G, Matson JR. Prospective evaluation of short-term, high-volume isovolemic hemofiltration on the hemodynamic course and outcome in patients with intractable circulatory failure resulting from septic shock. Crit Care Med 2000, 28:3581-3587. 10.1097/00003246-200011000-00001, 11098957.
8. Morgera S, Haase M, Kuss T, Vargas-Hein O, Zuckermann-Becker H, Melzer C, Krieg H, Wegner B, Bellomo R, Neumayer HH. Pilot study on the effects of high cutoff hemofiltration on the need for norepinephrine in septic patients with acute renal failure. Crit Care Med 2006, 34:2099-2104. 10.1097/01.CCM.0000229147.50592.F9, 16763508.
9. Peng ZY, Carter MJ, Kellum JA. Effects of hemoadsorption on cytokine removal and short-term survival in septic rats. Crit Care Med 2008, 36:1573-1577. 10.1097/CCM.0b013e318170b9a7, 3547590, 18434884.
10. Rimmelé T, Assadi A, Cattenoz M, Desebbe O, Lambert C, Boselli E, Goudable J, Etienne J, Chassard D, Bricca G, Allaouchiche B. High-volume haemofiltration with a new haemofiltration membrane having enhanced adsorption properties in septic pigs. Nephrol Dial Transplant 2009, 24:421-427.
11. Rimmelé T, Wey PF, Bernard N, Monchi M, Semenzato N, Benatir F, Boselli E, Etienne J, Goudable J, Chassard D, Bricca G, Allaouchiche B. Hemofiltration with the Cascade system in an experimental porcine model of septic shock. Ther Apher Dial 2009, 13:63-70. 10.1111/j.1744-9987.2009.00655.x, 19379172.
12. Ronco C, Brendolan A, Lonnemann G, Bellomo R, Piccinni P, Digito A, Dan M, Irone M, La Greca G, Inguaggiato P, Maggiore U, De Nitti C, Wratten ML, Ricci Z, Tetta C. A pilot study of coupled plasma filtration with adsorption in septic shock. Crit Care Med 2002, 30:1250-1255. 10.1097/00003246-200206000-00015, 12072677.
13. Maxvold NJ, Smoyer WE, Custer JR, Bunchman TE. Amino acid loss and nitrogen balance in critically ill children with acute renal failure: a prospective comparison between classic hemofiltration and hemofiltration with dialysis. Crit Care Med 2000, 28:1161-1165. 10.1097/00003246-200004000-00041, 10809299.
14. Deshpande P, Chen J, Gofran A, Murea M, Golestaneh L. Meropenem removal in critically ill patients undergoing sustained low-efficiency dialysis (SLED). Nephrol Dial Transplant 2010, 25:2632-2636. 10.1093/ndt/gfq090, 20181801.
15. Bouman CS. Antimicrobial dosing strategies in critically ill patients with acute kidney injury and high-dose continuous veno-venous hemofiltration. Curr Opin Crit Care 2008, 14:654-659. 10.1097/MCC.0b013e32830f937c, 19023912.
16. Rimmelé T, Kellum JA. Clinical review: blood purification for sepsis. Crit Care 2011, 15:205. 10.1186/cc9411, 3222040, 21371356.
17. Kellum JA, Song M, Venkataraman R. Hemoadsorption removes tumor necrosis factor, interleukin-6, and interleukin-10, reduces nuclear factor-kappaB DNA binding, and improves short-term survival in lethal endotoxemia. Crit Care Med 2004, 32:801-805. 10.1097/01.CCM.0000114997.39857.69, 15090965.
18. Morgera S, Haase M, Rocktäschel J, Böhler T, Vargas-Hein O, Melzer C, Krausch D, Kox WJ, Baumann G, Beck W, Göhl H, Neumayer HH. Intermittent high-permeability hemofiltration modulates inflammatory response in septic patients with multiorgan failure. Nephron Clin Pract 2003, 94:c75-80. 10.1159/000072024, 12902634.
19. Ono S, Tsujimoto H, Matsumoto A, Ikuta S, Kinoshita M, Mochizuki H. Modulation of human leukocyte antigen-DR on monocytes and CD16 on granulocytes in patients with septic shock using hemoperfusion with polymyxin B-immobilized fiber. Am J Surg 2004, 188:150-156. 10.1016/j.amjsurg.2003.12.067, 15249240.
20. Peng ZY, Wang HZ, Carter MJ, Dileo MV, Bishop JV, Zhou FH, Wen XY, Rimmelé T, Singbartl K, Federspiel WJ, Clermont G, Kellum JA. Acute removal of common sepsis mediators does not explain the effects of extracorporeal blood purification in experimental sepsis. Kidney Int 2012, 81:363-369. 10.1038/ki.2011.320, 3269547, 21918497.
21. Abe S, Seo Y, Hayashi H, Matsuda K, Usuki J, Azuma A, Kudoh S, Gemma A. Neutrophil adsorption by polymyxin B-immobilized fiber column for acute exacerbation in patients with interstitial pneumonia: a pilot study. Blood Purif 2010, 29:321-326. 10.1159/000287232, 20185904.
22. Kumagai T, Takeyama N, Yabuki T, Harada M, Miki Y, Kanou H, Inoue S, Nakagawa T, Noguchi H. Apheresis of activated leukocytes with an immobilized polymyxin B filter in patients with septic shock. Shock 2010, 34:461-466. 10.1097/SHK.0b013e3181e14ca0, 20386499.
23. Nishibori M, Takahashi HK, Katayama H, Mori S, Saito S, Iwagaki H, Tanaka N, Morita K, Ohtsuka A. Specific removal of monocytes from peripheral blood of septic patients by polymyxin B-immobilized filter column. Acta Med Okayama 2009, 63:65-69.
24. Novelli G, Ferretti G, Ruberto F, Morabito V, Pugliese F. Early management of endotoxemia using the endotoxin activity assay and polymyxin B-based hemoperfusion. Contrib Nephrol 2010, 167:91-101.
25. Ding F, Song JH, Jung JY, Lou L, Wang M, Charles L, Westover A, Smith PL, Pino CJ, Buffington DA, Humes HD. A biomimetic membrane device that modulates the excessive inflammatory response to sepsis. PLoS One 2011, 6:e18584. 10.1371/journal.pone.0018584, 3077371, 21533222.
26. Ding F, Yevzlin AS, Xu ZY, Zhou Y, Xie QH, Liu JF, Zheng Y, DaSilva JR, Humes HD. The effects of a novel therapeutic device on acute kidney injury outcomes in the intensive care unit: a pilot study. ASAIO J 2011, 57:426-432. 10.1097/MAT.0b013e31820a1494, 21317636.
27. Kanekura T, Hiraishi K, Kawahara K, Maruyama I, Kanzaki T. Granulocyte and monocyte adsorption apheresis (GCAP) for refractory skin diseases caused by activated neutrophils and psoriatic arthritis: evidence that GCAP removes Mac-1-expressing neutrophils. Ther Apher Dial 2006, 10:247-256. 10.1111/j.1744-9987.2006.00369.x, 16817789.
28. Saniabadi AR, Hanai H, Takeuchi K, Umemura K, Nakashima M, Adachi T, Shima C, Bjarnason I, Lofberg R. Adacolumn, an adsorptive carrier based granulocyte and monocyte apheresis device for the treatment of inflammatory and refractory diseases associated with leukocytes. Ther Apher Dial 2003, 7:48-59. 10.1046/j.1526-0968.2003.00012.x, 12921115.
29. Yonemura K, Ohashi N, Kajimura M, Hishida A. Transient leukopenia and anaphylatoxin production during granulocyte apheresis as treatment for ulcerative colitis. J Clin Apher 2002, 17:107-110. 10.1002/jca.10033, 12378544.
30. Levy MM, Fink MP, Marshall JC, Abraham E, Angus D, Cook D, Cohen J, Opal SM, Vincent JL, Ramsay G, SCCM/ESICM/ACCP/ATS/SIS 2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference. Crit Care Med 2003, 31:1250-1256. 10.1097/01.CCM.0000050454.01978.3B, 12682500, SCCM/ESICM/ACCP/ATS/SIS.
31. Cole L, Bellomo R, Journois D, Davenport P, Baldwin I, Tipping P. High-volume haemofiltration in human septic shock. Intensive Care Med 2001, 27:978-986. 10.1007/s001340100963, 11497156.
32. Ploppa A, Schmidt V, Hientz A, Reutershan J, Haeberle HA, Nohé B. Mechanisms of leukocyte distribution during sepsis: an experimental study on the interdependence of cell activation, shear stress and endothelial injury. Crit Care 2010, 14:R201. 10.1186/cc9322, 3220016, 21059228.
33. Neto HA, Kubes P. Platelets, endothelium and shear join forces to mislead neutrophils in sepsis. Crit Care 2011, 15:103. 3222017, 21349145.
34. Kroll MH, Hellums JD, McIntire LV, Schafer AI, Moake JL. Platelets and shear stress. Blood 1996, 88:1525-1541.
35. Peters MJ, Dixon G, Kotowicz KT, Hatch DJ, Heyderman RS, Klein NJ. Circulating platelet-neutrophil complexes represent a subpopulation of activated neutrophils primed for adhesion, phagocytosis and intracellular killing. Br J Haematol 1999, 106:391-399. 10.1046/j.1365-2141.1999.01553.x, 10460597.
36. Kornerup KN, Salmon GP, Pitchford SC, Liu WL, Page CP. Circulating platelet-neutrophil complexes are important for subsequent neutrophil activation and migration. J Appl Physiol 2010, 109:758-767. 10.1152/japplphysiol.01086.2009, 20558756.
37. Waugh DJ, Wilson C. The interleukin-8 pathway in cancer. Clin Cancer Res 2008, 14:6735-6741. 10.1158/1078-0432.CCR-07-4843, 18980965.
38. Batal I, Zeevi A, Heider A, Girnita A, Basu A, Tan H, Shapiro R, Randhawa P. Measurements of global cell-mediated immunity in renal transplant recipients with BK virus reactivation. Am J Clin Pathol 2008, 129:587-591. 10.1309/23YGPB1E758ECCFP, 18343786.
39. Kowalski R, Post D, Schneider MC, Britz J, Thomas J, Deierhoi M, Lobashevsky A, Redfield R, Schweitzer E, Heredia A, Reardon E, Davis C, Bentlejewski C, Fung J, Shapiro R, Zeevi A. Immune cell function testing: an adjunct to therapeutic drug monitoring in transplant management. Clin Tranplant 2003, 17:77-88.
40. Kumar P, Satchidanandam V. Ethyleneglycol-bis-(beta-aminoethylether)tetraacetate as a blood anticoagulant: preservation of antigen-presenting cell function and antigen-specific proliferative response of peripheral blood mononuclear cells from stored blood. Clin Diagn Lab Immunol 2000, 7:578-583. 95917, 10882655.
41. Ding F, Song JH, Jung JY, Lou L, Wang M, Charles L, Westover A, Smith PL, Pino CJ, Buffington DA, Humes HD. A biomimetic membrane device that modulates the excessive inflammatory response to sepsis. PLoS One 2011, 6:e18584. 10.1371/journal.pone.0018584, 3077371, 21533222.
42. Hoesel LM, Neff TA, Neff SB, Younger JG, Olle EW, Gao H, Pianko MJ, Bernacki KD, Sarma JV, Ward PA. Harmful and protective roles of neutrophils in sepsis. Shock 2005, 24:40-47.
43. Karzai W, Cui X, Heinicke N, Niemann C, Gerstenberger EP, Correa R, Banks S, Mehlhorn B, Bloos F, Reinhart K, Eichacker PQ. Neutrophil stimulation with granulocyte colony-stimulating factor worsens ventilator-induced lung injury and mortality in rats. Anesthesiology 2005, 103:996-1005. 10.1097/00000542-200511000-00014, 16249674.
44. Scholz M, Cinatl J, Schädel-Höpfner M, Windolf J. Neutrophils and the blood-brain barrier dysfunction after trauma. Med Res Rev 2007, 27:401-416. 10.1002/med.20064, 16758487.
45. Humes HD, Sobota JT, Ding F, Song JH, RAD Investigator Group A selective cytopheretic inhibitory device to treat the immunological dysregulation of acute and chronic renal failure. Blood Purif 2010, 29:183-190. 10.1159/000245645, 20093825, RAD Investigator Group.